Editas Medicine, Inc. (EDIT) vs Rezolute, Inc. (RZLT)
A side-by-side comparison of Editas Medicine, Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EDIT
Editas Medicine, Inc.
$2.84HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RZLT
Rezolute, Inc.
$4.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — EDIT vs RZLT
growth of $100 · dividends reinvested · last 10yEDIT -81.4% (-15.5%/yr)RZLT -94.6% (-25.3%/yr)EDIT compounded faster over this window
EDIT RZLT
EDIT vs RZLT: by the numbers
- •EDIT is the larger company ($435M vs $418M market cap).
- •Both run net losses; RZLT's is the smaller (0.00% vs -157.32% net margin).
Metrics side by side
Valuation
| Metric | EDIT | RZLT |
|---|---|---|
| P/S ratio | 9.26 | N/A |
| P/B ratio | 4.13 | 4.15 |
Profitability
| Metric | EDIT | RZLT |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -245.15% | 0.00% |
| Net margin | -157.32% | 0.00% |
| ROE | -70.24% | -77.06% |
| ROIC | -48.61% | -81.80% |
Growth (annualized)
| Metric | EDIT | RZLT |
|---|---|---|
| Revenue CAGR (5Y) | -10.34% | N/A |
| Total return CAGR (5Y) | -40.76% | -9.57% |
Frequently asked
- How have EDIT and RZLT total returns compared?
- Over the past 10 years, EDIT delivered -15.75% and RZLT delivered -25.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.